An unparalleled real-world evidence solution.

GuardantINFORM powers critical decision-making in oncology research, clinical development, and commercialization.

500k+ unique
patient profiles¹

24k+ patients sequenced with Guardant Infinity^™

60+ advanced/
metastatic solid
tumor types tested